Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 451-500 of 1332 result(s).
CYDY CytoDyn Inc
04/09/2025 11:10:15 AM
https://www.yahoo.com/finance/news (2)
CYDY CytoDyn Inc
04/09/2025 12:42:53 AM
2023 Trump tariffs for cancer & pha (1)
CYDY CytoDyn Inc
04/09/2025 12:18:00 AM
April 9th, 2025: President Donald T (2)
CYDY CytoDyn Inc
04/09/2025 12:11:50 AM
“We don’t make pharmaceuticals (2)
CYDY CytoDyn Inc
04/08/2025 12:37:18 AM
Max post month ago: While I am not (4)
CYDY CytoDyn Inc
04/08/2025 12:17:41 AM
Inflammation is a central feature o (4)
CYDY CytoDyn Inc
04/07/2025 10:22:46 PM
Dr. J said the ceo did not allow do (2)
CYDY CytoDyn Inc
04/07/2025 9:58:46 PM
You know...other day saw an adverti (3)
CYDY CytoDyn Inc
04/07/2025 9:32:31 PM
Niele: According to estimates, the (4)
CYDY CytoDyn Inc
04/07/2025 1:42:10 AM
An automatic Google result: CytoDyn (7)
CYDY CytoDyn Inc
04/06/2025 7:49:57 PM
Sean007 -- European Society for Med (3)
CYDY CytoDyn Inc
04/06/2025 5:55:59 PM
United States: Breast, lung and bro (7)
CYDY CytoDyn Inc
04/06/2025 10:01:38 AM
CCR5 & bacteria: CCR5 is a receptor (6)
CYDY CytoDyn Inc
04/05/2025 4:43:38 PM
Yep, DOD are always 1st to benefit (2)
CYDY CytoDyn Inc
04/05/2025 12:39:43 AM
Did LL cure Acinetobacter baumannii (7)
CYDY CytoDyn Inc
04/04/2025 8:10:33 PM
Penicillin & Leronlimab: From Scien (2)
CYDY CytoDyn Inc
04/04/2025 5:57:12 PM
NIH: Death rate attributed to NSAID (4)
CYDY CytoDyn Inc
04/04/2025 4:13:41 PM
Leronlimab/ Aspirin/ Penicillin: If (5)
CYDY CytoDyn Inc
04/04/2025 8:27:31 AM
Some types of solid tumors occur on (5)
CYDY CytoDyn Inc
04/03/2025 10:46:30 PM
H.R.1806 - Triple-Negative Breast C (3)
CYDY CytoDyn Inc
04/03/2025 9:20:48 PM
The global oncology drugs market is (5)
CYDY CytoDyn Inc
04/03/2025 3:36:16 PM
Right....& No: SAE's...drug-drug,,d (2)
CYDY CytoDyn Inc
04/03/2025 1:06:40 PM
12 months was Median --- 50/50. Las
CYDY CytoDyn Inc
04/03/2025 1:01:18 PM
No problem ---- they did a trial of (4)
CYDY CytoDyn Inc
04/03/2025 11:51:36 AM
Standard of Care: Trodelvy for mTNB (5)
CYDY CytoDyn Inc
04/02/2025 10:37:21 PM
Cytodyn Inc.'s research suggests th (4)
CYDY CytoDyn Inc
04/02/2025 3:12:43 PM
We've claimed Oncology/solid tumors (9)
CYDY CytoDyn Inc
04/01/2025 10:42:07 PM
Days ago on ST, the data collecting (1)
CYDY CytoDyn Inc
04/01/2025 10:24:44 PM
Thinking on what Bill Gated said ab
CYDY CytoDyn Inc
04/01/2025 2:16:27 PM
Huge overlooked Leronlimab advantag (6)
CYDY CytoDyn Inc
04/01/2025 2:03:23 PM
Website validates March news as ano (3)
CYDY CytoDyn Inc
04/01/2025 11:51:39 AM
Companies are responsible for the s (2)
CYDY CytoDyn Inc
04/01/2025 10:47:47 AM
So, the non-toxic, history making s (1)
CYDY CytoDyn Inc
04/01/2025 9:41:48 AM
TNBC - MOA and combination studies (5)
CYDY CytoDyn Inc
04/01/2025 7:12:33 AM
Yes sir...but did we ever know her (1)
CYDY CytoDyn Inc
03/31/2025 8:45:04 PM
HER2+ from patent application: CCR5 (17)
CYDY CytoDyn Inc
03/29/2025 11:17:29 PM
Didn't notice that...thx. Ivdon't d
CYDY CytoDyn Inc
03/27/2025 11:45:57 AM
The Assignee is Cytodyn. They've be (3)
CYDY CytoDyn Inc
03/27/2025 7:34:21 AM
Upon Patent approved, we own the be (3)
CYDY CytoDyn Inc
03/27/2025 7:03:09 AM
March 12th, 2020 only 350mg: The pa (12)
CYDY CytoDyn Inc
03/26/2025 11:56:41 AM
Yes sir....& RECOVER is Congress ma (8)
CYDY CytoDyn Inc
03/25/2025 7:44:25 PM
Video is from when CDC interviewed (2)
CYDY CytoDyn Inc
03/25/2025 7:35:40 PM
Cytodyn gave it back to Pestell. He (2)
CYDY CytoDyn Inc
03/25/2025 7:27:29 PM
Elected 2024: What is the Academia (1)
CYDY CytoDyn Inc
03/25/2025 2:14:27 PM
& Kat -- Dr. RP is going to shake t (4)
CYDY CytoDyn Inc
03/25/2025 2:47:47 AM
Mary Maxwell Gates, the mother of M (2)
CYDY CytoDyn Inc
03/25/2025 1:18:54 AM
Distinguished Researchers to Join H (8)
CYDY CytoDyn Inc
03/25/2025 1:03:08 AM
HUN-REN: "...which can make a signi (7)
CYDY CytoDyn Inc
03/23/2025 4:00:30 AM
Jan 10th, 2011 -- A new window of o (4)
CYDY CytoDyn Inc
03/22/2025 9:28:57 PM
February 21, 2019: “This is the f (8)
Go to page:
  • << First
  • < Previous
  • 9
  • 10
  • Next >

Recent Articles

  • C3.ai, Inc. Investors Encouraged to Review Class Action Details
  • Shareholder Class Action Against Semler Scientific: Key Insights
  • Understanding Legal Rights for Snap Inc. Stockholders
  • TIER IV Receives $7 Million Credit Line from SMTB
  • Bullish Expands Offerings with New Crypto Options Trading
  • Sae-A Trading Increases Market Presence with New Acquisition
  • Daniel Kingwell Celebrated as Top Immigration Lawyer in Canada
  • PREMIERE Group Expands Luxury Market with New Acquisition
  • Reflex Advanced Materials Updates on Management and Shares
  • Reflex Advanced Materials Reveals Key Corporate Developments
  • World Gym Corporation Expands Global Footprint Strategically
  • Support Future Leaders: Shield of Odin Sponsors Fundraiser Event
  • World Gym Corporation Expands Reach with Strategic Growth Plans
  • DIH Holding US, Inc.: Latest Insights on Nasdaq Compliance
  • HUTCHMED Unveils Promising Data at ESMO Congress 2025
  • DIH Holding US, Inc. Updates on Nasdaq Compliance Status
  • HUTCHMED's Promising Data Presentation at ESMO 2025 Event
  • BIGO Ads Renewed Commitment to Transparency in Advertising
  • Freed-Hardeman University Celebrates Remarkable Enrollment Growth
  • Oliveda International Hosts Unique Red Carpet Event for Ancient Trees
  • Unlocking the Wealth Potential of JPMorgan Chase Over Two Decades
  • Key Deadlines for Investors in Charter Communications Lawsuit
  • Aker Carbon Capture ASA Announces Updated Dividend Payments
  • ArtPrize 2025: Unveiling Unique Exhibitions and Artist Talent
  • Discover Exciting Scavenger Hunt for Sabrina Carpenter Tickets
  • Empowering Indigenous Communities Through Housing Solutions
  • Exploring the Booming Hydrogen Car Market and Its Growth Trends
  • Investors of Quantum Corporation Should Act Before Deadline
  • Hydrogen Vehicles Set to Expand to 353,000 Units by 2035
  • A Decade of Growth: The Success of Crocs Stock Investment
  • Innovative Research at PNRI: Breakthroughs in Rare Disease Treatment
  • Aker Carbon Capture ASA's Call for Extraordinary Meeting Insights
  • Mike Tyson Teams Up with GBank Financial in New Venture
  • The Growth Journey of Meta Platforms Stock Over 5 Years
  • Chris Leahy Honored as International Executive of the Year 2025
  • Advocating for Fair Prices in Prison Communication Solutions
  • Australian Hospitals Realizing Savings with Mobile Device Use
  • Las Vegas Police Embrace Cutting-Edge Cybertrucks for Patrols
  • Investing in Parker Hannifin: Value Growth Over a Decade
  • Investors Can Have a Voice in Fly-E Group, Inc. Case
  • Get Ready for Prairie View A&M University's Epic Homecoming
  • RBB Bancorp to Release Third Quarter Financial Results Soon
  • Transforming $1000 into a Winning Investment with Valero Energy
  • Snap Inc. Investors: Key Actions Required Ahead of Deadline
  • Discover the Benefits of Flex Seal Draft & Insulation Tape
  • Gastelum Attorneys and Opportunity Village Unite for Haunted Event
  • Quiana Bishop Takes Charge as DPC Board President to Advocate for Patients
  • Stocktwits Unveils Exciting Stocktoberfest Festival Event
  • Investors in KinderCare Learning Companies Can Take Action
  • Jimmy Fallon Adjusts His Late-Night Strategy Amid Changes
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site